Synthetic antioxidant TS-13 reduces doxorubicin cardiotoxicity
The antitumor antibiotic doxorubicin, a representative of a large group of anthriacyclines, is widely and quite effectively used to treat patients with malignant neoplasms. The aim of this study was to study the effect of TS-13, a synthetic phenolic antioxidant and an activator of the antioxidant-re...
Salvato in:
| Autori principali: | , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Russo |
| Pubblicazione: |
Russian Academy of Sciences, Siberian Branch Publishing House
2023-10-01
|
| Serie: | Сибирский научный медицинский журнал |
| Soggetti: | |
| Accesso online: | https://sibmed.elpub.ru/jour/article/view/1248 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|